Email
Additional details on the product performance issue
Sep 30, 2025 01:16 PM
Hi Victor,
Thank you for sharing this additional information. @Kevin Kopp from our technical team is reviewing and will reply within the next 1-2 business days with an update.
Thank you,
Andrew Hartmann
Business Development Manager
–
25020 Avenue Tibbitts
Valencia, CA 91355
–
D +1.661.567.0667
P +1.888.UTAK.LAB
F +1.661.294.9272
–
Book a Meeting with Me
https://calendly.com/ahartmann-utak/30min
utak.com
From: Victor Asirvatham <victor.asirvatham@genesisreferencelabs.com>
Sent: Monday, September 29, 2025 5:35 PM
To: Andrew Hartmann <ahartmann@utak.com>
Cc: Kevin Kopp <kevin@utak.com>
Subject: Re: COA - CID#100461
Hi Andrew, Take a look at the LJ chart before and after we lot # D4778 into use on 08/01/25. This is hydrocodone. Several others are also giving around 30% recoveries compared to the nominal values.
Field Required Customer Entry
Customer Identification Number (CID) 100461
Contact Name Victor Asirvatham
Contact Email Victor.asirvatham@genesisreferencelabs.com
Sales Order #
(or) Lot#
(or) Part#
*Two of the three are required Lot #D4778
Part # 50701
What happened?
(e.g., Part number 1234 was shipped) Recovery doesn’t the IFU sheet
What should have happened?
(e.g., part number XYZ should have been shipped) Recoveries should be within 20% from the nominal values
Additional Comments
(e.g., steps already taken to troubleshoot, additional notes, or preferred resolutions) Previous lot DAU high 2 were good